Use of an inhibitor of HER2 dimerization of receptor Tyrosine Kinases for the manufacture of a drug to increase the time until the disease progression or Survival in cancer patients

摘要

Describes how to lengthen the time prior to disease progression or Survival in cancer patients with Activation of her, treating the patient with a her dimerization inhibitor as pertuzumab.